Cargando…
Including non-concurrent control patients in the analysis of platform trials: is it worth it?
BACKGROUND: Platform trials allow adding new experimental treatments to an on-going trial. This feature is attractive to practitioners due to improved efficiency. Nevertheless, the operating characteristics of a trial that adds arms have not been well-studied. One controversy is whether just the con...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315495/ https://www.ncbi.nlm.nih.gov/pubmed/32580702 http://dx.doi.org/10.1186/s12874-020-01043-6 |